Zhi-Yan Hu
Overview
Explore the profile of Zhi-Yan Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao Y, Ihmsen H, Hu Z, Sun W, Fang Y, Wang Z, et al.
Br J Anaesth
. 2023 Sep;
131(5):914-920.
PMID: 37739904
Background: The pharmacokinetic properties of the new benzodiazepine remimazolam have been studied only in adults. We investigated the pharmacokinetics of remimazolam after i.v. infusion in anaesthetised paediatric patients. Methods: Twenty-four...
2.
Gao L, Zhong Y, Long T, Wang X, Zhu J, Wang X, et al.
J Exp Clin Cancer Res
. 2022 Mar;
41(1):81.
PMID: 35241150
Background: Tumor budding is included in the routine diagnosis of colorectal cancer (CRC) and is considered a tumor prognostic factor independent of TNM staging. This study aimed to identify the...
3.
Zhong Y, Long T, Gu C, Tang J, Gao L, Zhu J, et al.
Cell Death Differ
. 2021 Jun;
28(12):3251-3269.
PMID: 34131310
Tumour metastasis is a major reason accounting for the poor prognosis of colorectal cancer (CRC), and the discovery of targets in the primary tumours that can predict the risk of...
4.
Zhu H, Liu Y, Liu D, Ma Y, Hu Z, Wang X, et al.
Oncogenesis
. 2019 Aug;
8(8):43.
PMID: 31409774
Hepatocellular carcinoma (HCC) is a leading cause of tumour-associated mortality worldwide, but no significant improvement in treating HCC has been reported with currently available systemic therapies. Immunotherapy represents a new...
5.
Wang C, Ihmsen H, Hu Z, Chen J, Ye X, Chen F, et al.
Front Pharmacol
. 2019 Jul;
10:756.
PMID: 31333469
Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations...
6.
Zhu H, Zhang X, Gu C, Zhong Y, Long T, Ma Y, et al.
Cancer Biol Ther
. 2019 Mar;
20(7):967-978.
PMID: 30894065
Nontumour cells in the tumour microenvironment, especially fibroblasts, contribute to tumour progression and metastasis. The occurrence and evolution of colorectal cancer (CRC) is closely related to cancer-associated fibroblasts (CAFs). The...
7.
Wang Z, Shen X, Chen J, Jiang Y, Hu Z, Wang X, et al.
Int J Biol Macromol
. 2018 Jun;
117:721-726.
PMID: 29864537
Herein, an efficient DES/MIBK biphasic pretreatment system for preparation of furfural and fermentable glucose from lignocellulose was developed with AlCl as catalysis. The low-cost and renewable DES (Choline chloride-Oxalic acid)...
8.
RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
Wang X, Li S, Zhu H, Hu Z, Zhong Y, Gu C, et al.
Sci Rep
. 2017 May;
7:46078.
PMID: 28470188
Response gene to complement 32 (RGC32) is a transcription factor that regulates the expression of multiple genes involved in cell growth, viability and tissue-specific differentiation. However, the role of RGC32...
9.
Liu Y, Zhu H, Liu D, Hu Z, Li S, Kan H, et al.
Oncotarget
. 2016 Oct;
7(47):77306-77318.
PMID: 27764793
Decoy receptor 3 (DcR3), a novel member of the tumor necrosis factor receptor (TNFR) family, was recently reported to be associated with tumorigenesis and metastasis. However, the role of DcR3...
10.
Hu Z, Liu Y, Xie L, Wang X, Yang F, Chen S, et al.
Biochim Biophys Acta
. 2016 Apr;
1862(6):1172-81.
PMID: 27039663
Our previous studies have shown that PRKA kinase anchor protein 9 (AKAP-9) is involved in colorectal cancer (CRC) cell proliferation and migration in vitro. However, whether or not AKAP-9 is...